Prevalence and Risk Factors of Women Mental Health Disorders

Overview

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. On the other hand, Depressive disorder in women mainly occurs during the first year after childbirth. It takes many forms according to the onset, severity, and duration of the symptoms including; Postpartum blues (PPB), Postpartum depression (PPD), and Postpartum psychosis (PPP). Lack of access to mental health services during the perinatal period is a significant public health concern that may worse outcome. So, we aimed to study prevalence of women mental health in Assiut governorate and evaluate possible risk factor for it

Full Title of Study: “Prevalence and Risk Factors of Women Mental Health Disorders in Assiut Governorate”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: September 1, 2022

Interventions

  • Behavioral: Sociodemographic variables
    • age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.
  • Behavioral: Family affluence scale (FAS)
    • a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.
  • Behavioral: Edinburgh postnatal depression scale (EPDS)
    • s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed
  • Behavioral: Symptom Checklist 90 “SCL 90”:
    • is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

Arms, Groups and Cohorts

  • Perinatal group
    • females who are pregnancy
  • postpartum group
    • female who get delivery(from day 1 up to 1 year)

Clinical Trial Outcome Measures

Primary Measures

  • measure the prevalence of DSM 5 psychiatric disorders in perinatal and postnatal
    • Time Frame: through study completion, an average of 1 year
  • measure of risk factor of DSM 5 psychiatric disorders in perinatal and postnatal
    • Time Frame: through study completion, an average of 1 year

Participating in This Clinical Trial

Inclusion Criteria

  • age 18 years -50 years. – No previous history of psychiatric, neurological or medical disease Exclusion Criteria:

  • intelligence equation less than 80 – have history of psychiatric, neurological or medical disease

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Assiut University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Gellan Karamalllah Ramadan Ahmed, lecturer, resarcher OF Neurology and Psychiatry department – Assiut University
  • Overall Contact(s)
    • gellan Ahmed, +201093663928, gillankaram@aun.edu.eg

References

Sambrook Smith M, Lawrence V, Sadler E, Easter A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta-synthesis of qualitative studies in the UK. BMJ Open. 2019 Jan 24;9(1):e024803. doi: 10.1136/bmjopen-2018-024803.

Citations Reporting on Results

Sheffield KM, Woods-Giscombe CL. Efficacy, Feasibility, and Acceptability of Perinatal Yoga on Women's Mental Health and Well-Being: A Systematic Literature Review. J Holist Nurs. 2016 Mar;34(1):64-79. doi: 10.1177/0898010115577976. Epub 2015 Apr 20.

Sharma V, Burt VK. DSM-V: modifying the postpartum-onset specifier to include hypomania. Arch Womens Ment Health. 2011 Feb;14(1):67-9. doi: 10.1007/s00737-010-0182-2. Epub 2010 Sep 25.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.